Most people asking about Spravato aren’t trying to learn what it is. They’re trying to figure out whether they still need to take antidepressants that haven’t helped them much. That’s the real situation behind this question. By the time it comes up, most patients have already gone through multiple medications, waited through side effects, adjusted doses, and still feel stuck.
WC Health sees this pattern often. Patients come in after years of trying medications that haven’t moved the needle — and they’re looking for a different path forward for their depression treatment in Las Vegas.
Spravato can be used without a daily antidepressant now, but only in a very specific context. It becomes an option when antidepressants have already been tried properly and are no longer providing meaningful benefit. Outside of that, removing daily medication is not part of standard care.
What the Evidence Actually Supports
The strongest clinical evidence behind Spravato comes from studies where it was used with an oral antidepressant.
In trials like TRANSFORM-2, patients had treatment-resistant depression and were started on a new oral antidepressant. Spravato was added on top of that. Compared to placebo, patients receiving Spravato showed greater reductions in depressive symptoms. The improvement wasn’t exaggerated, but it was meaningful in a group that had already failed prior treatments.
Long-term data from studies like SUSTAIN-1 showed that patients who continued Spravato were less likely to relapse than those who stopped. That tells us two important things:
- Spravato can maintain improvement over time
- stopping treatment increases the risk of symptoms returning
The key limitation is this:
👉 These results are based on combination treatment, not Spravato alone.
That doesn’t mean monotherapy doesn’t work. It means the evidence supporting it is less direct.
Who Qualifies for Spravato Without Antidepressants?
The shift toward allowing Spravato without a daily antidepressant didn’t come from one definitive study proving it works better alone. It came from consistent clinical observation.
Some patients were improving with Spravato even when the antidepressant they were taking wasn’t helping. In those cases, continuing the antidepressant added side effects or burden without improving outcomes.
Regulatory updates now allow Spravato to be used without a daily antidepressant in certain cases of treatment-resistant depression. That change gives clinicians flexibility — and it’s part of why more patients exploring treatment-resistant depression treatment are asking about this option.
This is a structural change, not a new treatment model. The core evidence still comes from combination use.
What Counts as “Antidepressants Have Failed”
This is one of the most misunderstood parts of the decision.
Failure doesn’t mean trying medication for a week and stopping. It usually means:
- taking at least two antidepressants from different classes
- using them at therapeutic doses
- continuing for at least 6–8 weeks each
- seeing little to no meaningful improvement
Adherence matters here. If medications weren’t taken consistently or long enough, they don’t count as true trials.
This definition is what separates someone who qualifies for Spravato from someone who still has standard options left.
When It Makes Sense to Remove the Antidepressant
Spravato is used without a daily antidepressant when keeping that medication no longer adds value.
That usually looks like:
- multiple failed medication trials
- persistent symptoms despite adherence
- side effects that interfere with daily life
- taking a medication that no longer produces noticeable benefit
At that point, continuing another antidepressant often repeats the same mechanism without changing the outcome.
Removing it is not about simplifying treatment. It’s about stopping something that has already shown it doesn’t work.
When the Antidepressant Should Stay
Even in treatment-resistant depression, antidepressants are not automatically removed.
They are usually kept when:
- there is partial improvement
- the patient feels worse when the medication is reduced
- baseline stability still depends on it
This is a critical distinction. A medication doesn’t have to be fully effective to still be useful. If it contributes anything measurable, removing it too early can destabilize progress.
Spravato Treatment at WC Health in Las Vegas
Spravato is not taken at home. Every session happens at a certified clinic under direct medical supervision — which is why finding the right Spravato clinic near you in Las Vegas matters before you start.
Each session involves:
- intranasal dosing under medical observation
- monitoring for at least two hours
- tracking for dissociation, sedation, and blood pressure changes
Blood pressure monitoring matters because Spravato can cause temporary increases shortly after dosing. Dissociation matters because patients can feel disconnected or altered during the session. These effects are expected but need to be observed.
Patients cannot drive after treatment and must arrange transportation home.
Treatment Schedule and Structure
Treatment is not occasional. It follows a structured schedule:
- twice weekly during the first phase
- then weekly
- then every one to two weeks depending on response
When Spravato is used without a daily antidepressant, these sessions become the primary source of symptom control.
That means consistency matters more. Missing sessions is not a small issue—it can directly affect outcomes.
What Happens If You Miss or Stop Treatment
This is where many patients are caught off guard.
Spravato does not provide continuous coverage like daily antidepressants. Its effects depend on regular dosing.
If sessions are missed:
- symptom control can weaken
- depressive symptoms can return
Relapse-prevention data supports this. Patients who stop treatment are more likely to experience symptom recurrence than those who continue.
This doesn’t mean treatment is permanent. It means stopping requires planning, not assumption.
Why Spravato Treatment Is Not Just a Clinical Decision
Treatment with Spravato comes with practical limitations:
- It must be given in certified clinics under a monitoring program
- Each visit takes several hours
- Transportation is required after every session
- Insurance approval can take time
- Access may be limited depending on location
These factors affect whether treatment is realistic, not just whether it is appropriate. For patients in the Las Vegas area, WC Health is set up specifically to handle the scheduling, monitoring, and coordination that Spravato treatment requires.
Where This Approach Does Not Fit
Spravato without an antidepressant is not appropriate for everyone.
It is generally avoided when:
- antidepressants have not been fully tried
- bipolar disorder is not stabilized
- psychotic symptoms are present
- substance use is uncontrolled
- consistent clinic attendance is not possible
In these situations, removing baseline medication can reduce stability rather than improve it.
What This Decision Really Comes Down To
Most people aren’t asking about Spravato in theory. They’re asking whether they can stop taking something that isn’t helping.
The real decision is simple:
- If the antidepressant is still helping → it stays
- If it clearly isn’t → it can be removed
Spravato does not replace treatment. It replaces what has already failed.
Get a Clear Answer for Your Situation
If you’re unsure whether your current antidepressant is still helping, WC Health can review your treatment history and clarify whether Spravato monotherapy makes sense for your situation. Schedule a confidential consultation in Las Vegas today.
